HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mandip Singh Selected Research

Skin Neoplasms (Skin Cancer)

6/2019Combination of UVB Absorbing Titanium Dioxide and Quercetin Nanogel for Skin Cancer Chemoprevention.
1/2018Drug delivery strategies for chemoprevention of UVB-induced skin cancer: A review.
10/2016Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.
7/2016Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.
7/2015Enhanced Percutaneous Delivery of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) Methane for Skin Cancer Chemoprevention.
1/2013Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mandip Singh Research Topics

Disease

48Neoplasms (Cancer)
11/2022 - 02/2004
17Lung Neoplasms (Lung Cancer)
05/2022 - 09/2006
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 09/2006
13Triple Negative Breast Neoplasms
11/2022 - 03/2011
9Inflammation (Inflammations)
09/2021 - 01/2004
8Neoplasm Metastasis (Metastasis)
09/2021 - 05/2013
6Skin Neoplasms (Skin Cancer)
06/2019 - 01/2013
5Breast Neoplasms (Breast Cancer)
10/2018 - 01/2014
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017 - 01/2004
3Weight Loss (Weight Reduction)
09/2015 - 11/2010
3Allergic Contact Dermatitis
06/2014 - 01/2004
2Hyperplasia
01/2017 - 07/2016
2Cardiovascular Diseases (Cardiovascular Disease)
03/2016 - 01/2016
2Contact Dermatitis (Eczema, Contact)
01/2004 - 01/2004
1Peripheral Nervous System Diseases (PNS Diseases)
06/2022
1Neuralgia (Stump Neuralgia)
06/2022
1Ganglion Cysts (Ganglion)
06/2022
1Adenocarcinoma of Lung
11/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2019
1Ureteral Obstruction
09/2019

Drug/Important Bio-Agent (IBA)

16Pharmaceutical PreparationsIBA
11/2021 - 01/2013
16Docetaxel (Taxotere)FDA Link
11/2021 - 01/2006
13Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2007
11Liposomes (Liposome)IBA
01/2020 - 06/2003
7Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 03/2011
7Telmisartan (Micardis)FDA Link
05/2022 - 11/2013
7LipidsIBA
01/2021 - 05/2013
6Cisplatin (Platino)FDA LinkGeneric
02/2021 - 03/2011
6Noscapine (Narcotine)IBA
11/2017 - 12/2008
5Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021 - 01/2017
5Small Interfering RNA (siRNA)IBA
01/2019 - 08/2013
5SolutionsIBA
10/2018 - 09/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 01/2006
5Caspase 3 (Caspase-3)IBA
01/2014 - 09/2006
4ErbB Receptors (EGF Receptor)IBA
05/2022 - 10/2015
4Tyrosine Kinase InhibitorsIBA
05/2022 - 07/2018
4VimentinIBA
11/2019 - 01/2014
43,3'-diindolylmethane (diindolylmethane)IBA
11/2016 - 01/2009
4Peptides (Polypeptides)IBA
01/2016 - 01/2004
4SurvivinIBA
10/2015 - 11/2010
4Messenger RNA (mRNA)IBA
01/2014 - 09/2006
4PPAR gammaIBA
01/2009 - 02/2004
3CannabidiolIBA
11/2022 - 09/2021
3RNA (Ribonucleic Acid)IBA
06/2022 - 06/2014
3HydrogelsIBA
11/2021 - 12/2019
3CateninsIBA
12/2019 - 10/2013
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2016 - 10/2015
3LigandsIBA
05/2016 - 10/2015
3CollagenIBA
01/2016 - 01/2016
3Celecoxib (Celebrex)FDA Link
05/2013 - 01/2006
3spantide IIIBA
10/2005 - 01/2004
2osimertinibIBA
05/2022 - 01/2021
2Polysaccharides (Glycans)IBA
11/2021 - 01/2020
2rociletinibIBA
09/2021 - 07/2018
2Sorafenib (BAY 43-9006)FDA Link
09/2021 - 07/2018
2AlginatesIBA
12/2019 - 01/2016
2withaferin AIBA
11/2019 - 09/2019
2Sunscreening Agents (Sunscreens)IBA
06/2019 - 07/2016
2IntegrinsIBA
04/2018 - 05/2016
2Tacrolimus (Prograf)FDA LinkGeneric
04/2018 - 01/2017
2Cholecalciferol (Vitamin D3)FDA Link
04/2018 - 02/2018
2Phosphotransferases (Kinase)IBA
11/2017 - 11/2010
2Imiquimod (Aldara)FDA LinkGeneric
01/2017 - 01/2016
2GemcitabineFDA Link
01/2017 - 01/2011
2Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2016 - 01/2016
21,1- bis(3'- indolyl)- 1- (4- hydroxyphenyl)methaneIBA
05/2016 - 05/2016
2Orphan Nuclear ReceptorsIBA
10/2015 - 01/2013
21,1- bis(3'- indolyl)- 1- (4- biphenyl)methaneIBA
10/2014 - 07/2014
2Antineoplastic Agents (Antineoplastics)IBA
10/2014 - 01/2013
2Cyclin D1IBA
01/2014 - 11/2010
2AerosolsIBA
11/2010 - 09/2006
2EnzymesIBA
09/2006 - 02/2004
2Dinoprostone (PGE2)FDA Link
09/2006 - 01/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2006 - 02/2004
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2006 - 02/2004
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2004 - 01/2004
2Substance PIBA
01/2004 - 01/2004
1Paclitaxel (Taxol)FDA LinkGeneric
06/2022
1Apoptosis Regulatory ProteinsIBA
05/2022
1Sirolimus (Rapamycin)FDA Link
11/2020
1Endosomal Sorting Complexes Required for TransportIBA
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2020
1SynteninsIBA
01/2020
1methyl 2- cyano- 3,11- dioxo- 18beta- olean- 1,12- dien- 30- oateIBA
01/2020
1GelatinIBA
12/2019
1beta CateninIBA
12/2019
1Dactinomycin (Actinomycin)FDA LinkGeneric
12/2019
1Angiotensin Receptor AntagonistsIBA
12/2019
1LactonesIBA
09/2019
1Immunologic Factors (Immunomodulators)IBA
09/2019
1titanium dioxide (Titania)FDA Link
06/2019
1AntioxidantsIBA
06/2019
1Hormones (Hormone)IBA
06/2019
1QuercetinIBA
06/2019

Therapy/Procedure

13Therapeutics
11/2022 - 05/2013
6Chemoprevention
06/2019 - 01/2013
5Drug Therapy (Chemotherapy)
01/2020 - 01/2011
4Oral Administration
11/2017 - 12/2008
1Ligation
11/2019